Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - bmj, 2018 - bmj.com
Objective To investigate the associations between direct oral anticoagulants (DOACs) and
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …

[HTML][HTML] Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - The BMJ, 2018 - ncbi.nlm.nih.gov
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort
study in primary care - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

[PDF][PDF] Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - bmj, 2018 - core.ac.uk
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort
study in primary care Page 1 the bmj | BMJ 2018;362:k2505 | doi: 10.1136/bmj.k2505 1 …

[PDF][PDF] Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - bmj, 2018 - scholar.archive.org
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort
study in primary care Page 1 the bmj | BMJ 2018;362:k2505 | doi: 10.1136/bmj.k2505 1 …

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.

Y Vinogradova, C Coupland, T Hill… - … (Clinical Research ed …, 2018 - europepmc.org
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort
study in primary care. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill… - BMJ (Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective To investigate the associations between direct oral anticoagulants (DOACs) and
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting

Y Vinogradova, C Coupland, T Hill… - BMJ: British Medical …, 2018 - JSTOR
Objective To investigate the associations between direct oral anticoagulants (DOACs) and
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill… - British Medical …, 2018 - ora.ox.ac.uk
OBJECTIVE: To investigate the associations between direct oral anticoagulants (DOACs)
and risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill… - BMJ - nottingham-repository.worktribe.com
Objective: To investigate the associations between direct oral anticoagulants (DOACs) and
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …

[HTML][HTML] Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - BMJ, 2018 - bmj.com
Objective To investigate the associations between direct oral anticoagulants (DOACs) and
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …